Evidence map›Paper›PMID 34737336›Full record

ArticleScientific reports2021

Assessing short-term risk of ischemic stroke in relation to all prescribed medications.

Imre Janszky, Ioannis Vardaxis, Bo Henry Lindqvist, Jens Wilhelm Horn, Ben Michael Brumpton, Linn Beate Strand, Inger Johanne Bakken, Ingvild Vatten Alsnes, Pål Richard Romundstad, Rickard Ljung and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Imre JanszkyDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Håkon Jarls gate 11 and Mauritz Hanssens gate 2, Trondheim, Norway. imre.janszky@ntnu.no.
Ioannis VardaxisDepartment of Mathematical Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Bo Henry LindqvistDepartment of Mathematical Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Jens Wilhelm HornDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Håkon Jarls gate 11 and Mauritz Hanssens gate 2, Trondheim, Norway.
Ben Michael BrumptonClinic of Medicine, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
Linn Beate StrandDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Håkon Jarls gate 11 and Mauritz Hanssens gate 2, Trondheim, Norway.
Inger Johanne BakkenDepartment of Health Registries, Norwegian Directorate of Health, Trondheim, Norway.
Ingvild Vatten AlsnesDepartment of Public Health, University of Stavanger, Stavanger, Norway.
Pål Richard RomundstadDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Håkon Jarls gate 11 and Mauritz Hanssens gate 2, Trondheim, Norway.
Rickard LjungUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Solna, Stockholm, Sweden.
Kenneth Jay MukamalDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Abhijit SenDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Håkon Jarls gate 11 and Mauritz Hanssens gate 2, Trondheim, Norway.
Norwegian University of Science and Technology · NOBeth Israel Deaconess Medical Center · USKarolinska Institutet · SENorwegian Directorate of Health · NOUniversity of Stavanger · NO

Funding

The Central Norway Regional Health Authority 46060913
6 · The paper itself

Abstract

We examined the short-term risk of stroke associated with drugs prescribed in Norway or Sweden in a comprehensive, hypothesis-free manner using comprehensive nation-wide data. We identified 27,680 and 92,561 cases with a first ischemic stroke via the patient- and the cause-of-death registers in Norway (2004-2014) and Sweden (2005-2014), respectively, and linked these data to prescription databases. A case-crossover design was used that compares the drugs dispensed within 1 to 14 days before the date of ischemic stroke occurrence with those dispensed 29 to 42 days before the index event. A Bolasso approach, a version of the Lasso regression algorithm, was used to select drugs that acutely either increase or decrease the apparent risk of ischemic stroke. Application of the Bolasso regression algorithm selected 19 drugs which were associated with increased risk for ischemic stroke and 11 drugs with decreased risk in both countries. Morphine in combination with antispasmodics was associated with a particularly high risk of stroke (odds ratio 7.09, 95% confidence intervals 4.81-10.47). Several potentially intriguing associations, both within and across pharmacological classes, merit further investigation in focused, follow-up studies.

Indexed as

AdultAgedAged, 80 and overAlgorithmsBrain IschemiaCause of DeathDatabases, FactualFemaleFollow-Up StudiesHumansIschemic StrokeMaleMiddle AgedNorwayOdds RatioPrescription DrugsPrescription Drugs

Identifiers

PMID34737336
PMCPMC8568938
OpenAlexW3208759045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.